Screening for Type 2 diabetes: is it worthwhile?
The belief that screening for Type 2 diabetes is worthwhile is based not on evidence for the effectiveness of screening, but rather on a complex interaction of factors including perceptions of patient desires and an interplay of previous experience and evidence from other sources. Increased resources would be most likely to promote screening in primary care.
MR is weakly predictive of SLN status but it is not an independent predictor of survival for melanomas 1.0 mm or thicker.